(Q37869033)

24 August 2017

title

Viagra deafness--sensorineural hearing loss and phosphodiesterase-5 inhibitors (English)

1 reference

24 August 2017

1 reference

1 reference

Afroze Shah Khan

1

1 reference

24 August 2017

Zishan Sheikh

2

1 reference

24 August 2017

Shahnawaz Khan

3

1 reference

24 August 2017

Raghav Dwivedi

4

1 reference

24 August 2017

Elliot Benjamin

5

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

24 August 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

The Laryngoscope

1 reference

24 August 2017

volume

121

1 reference

24 August 2017

issue

5

1 reference

24 August 2017

page(s)

1049-1054

1 reference

Phosphodiesterase type 5 inhibitors in pulmonary arterial hypertension

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

A case of sensorineural deafness following ingestion of sildenafil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

Sudden hearing loss from PDE-5 inhibitors: A possible cellular stress etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

Phosphodiesterase type 5 inhibitor use and hearing impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

Effect of phosphodiesterase-5 inhibitor on hearing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

High dosage sildenafil induces hearing impairment in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

Sudden or fluctuating hearing loss and vertigo in children due to perilymph fistula

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

Steroids for idiopathic sudden sensorineural hearing loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

Treatment of sudden sensorineural hearing loss: II. A Meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

The nitric oxide/cyclic GMP pathway: a potential major regulator of cochlear physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

Halothane and isoflurane inhibit vasodilation due to constitutive but not inducible nitric oxide synthase. Implications for the site of anesthetic inhibition of the nitric oxide/guanylyl cyclase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

Nuclear factor kappaB deficiency is associated with auditory nerve degeneration and increased noise-induced hearing loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

Under-reporting of adverse drug reactions : a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

Pathology and pathophysiology of idiopathic sudden sensorineural hearing loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FLARY.21450

21 January 2018

Identifiers

DOI

10.1002/LARY.21450

1 reference

24 August 2017

1 reference